NCT00258895: Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®
- State
- Completed
- Phase
- Phase 3
- People
- 649 taking part
- Started
- Mar 2005
- Primary completion
- Dec 2006
- Arms
- DAPTACEL Primed, Pentacel Primed
- Results
- Posted on the registry
- 28 Nov 2005: Trial registered
- 28 Sep 2009: Trial results posted